Kyverna Therapeutics: Immune Reset Is Clinically Validated, Market Ignores Potential

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

From Barbie to Coach: Adobe is reinventing design with AI

Adobe’s agentic AI tools are turbocharging brand creativity, leading to fast, collaborative, and deeply human campaigns. For ...